Aarskog-Scott syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:915OMIM:100050Q87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aarskog-Scott syndrome, also known as Aarskog syndrome, faciogenital dysplasia, or facio-digito-genital syndrome, is a rare genetic disorder primarily characterized by distinctive abnormalities of the face, limbs, and genitalia. It predominantly affects males, though females may show milder features. The condition is caused by mutations in the FGD1 gene located on the X chromosome, which encodes a protein involved in cell signaling and skeletal development. Key clinical features include short stature, a round face with a broad forehead, widely spaced eyes (hypertelorism), a small nose with anteverted nostrils, a long philtrum, and a widow's peak hairline. Hand abnormalities are common and include short broad hands, brachydactyly (short fingers), clinodactyly (curved fifth fingers), and interdigital webbing. A hallmark genital finding in males is the "shawl scrotum," in which scrotal tissue surrounds the base of the penis. Other features may include mild to moderate short stature, joint hypermobility, inguinal hernias, and undescended testes. Some individuals may have mild intellectual disability or attention difficulties, though cognitive function is often normal. There is no cure for Aarskog-Scott syndrome, and management is supportive and symptom-based. Growth hormone therapy may be considered for significant short stature, and surgical correction may be needed for cryptorchidism, inguinal hernias, or other structural anomalies. Orthodontic treatment may address dental abnormalities. Regular developmental assessments are recommended for children, and educational support may be beneficial for those with learning difficulties. Prognosis is generally favorable, with most affected individuals having a normal life expectancy.

Also known as:

Clinical phenotype terms— hover any for plain English:

Shawl scrotumHP:0000049Broad palmHP:0001169Broad footHP:0001769
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Aarskog-Scott syndrome.

View clinical trials →

No actively recruiting trials found for Aarskog-Scott syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Aarskog-Scott syndrome community →

No specialists are currently listed for Aarskog-Scott syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aarskog-Scott syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aarskog-Scott syndromeForum →

No community posts yet. Be the first to share your experience with Aarskog-Scott syndrome.

Start the conversation →

Latest news about Aarskog-Scott syndrome

No recent news articles for Aarskog-Scott syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aarskog-Scott syndrome

What is Aarskog-Scott syndrome?

Aarskog-Scott syndrome, also known as Aarskog syndrome, faciogenital dysplasia, or facio-digito-genital syndrome, is a rare genetic disorder primarily characterized by distinctive abnormalities of the face, limbs, and genitalia. It predominantly affects males, though females may show milder features. The condition is caused by mutations in the FGD1 gene located on the X chromosome, which encodes a protein involved in cell signaling and skeletal development. Key clinical features include short stature, a round face with a broad forehead, widely spaced eyes (hypertelorism), a small nose with an

How is Aarskog-Scott syndrome inherited?

Aarskog-Scott syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aarskog-Scott syndrome typically begin?

Typical onset of Aarskog-Scott syndrome is childhood. Age of onset can vary across affected individuals.